SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-025930
Filing Date
2023-04-28
Accepted
2023-04-28 06:00:11
Documents
1
Period of Report
2023-04-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5470
  Complete submission text file 0001209191-23-025930.txt   6995
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TRACON PHARMACEUTICALS, INC. 4350 LA JOLLA VILLAGE DRIVE, SUITE 800 SAN DIEGO CA 92122
Business Address
THEUER CHARLES (Reporting) CIK: 0001631338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36818 | Film No.: 23859804